Starling Oncology, Inc. Investment Income, Interest
Starling Oncology, Inc. (STLN) reported Investment Income, Interest of $5.80 thousand for the 3-month period ending 2021-09-30, per its 10-Q/A filed 2021-12-14.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2021-12-14
- Starling Oncology, Inc. investment income, interest for the quarter ending 2021-09-30 was $5.80K, a 92.10% decline year-over-year.
- Starling Oncology, Inc. investment income, interest for the quarter ending 2021-06-30 was $6.72K, a 91.48% decline year-over-year.
- Starling Oncology, Inc. investment income, interest for the quarter ending 2021-03-31 was $45.96K, a 7.67% increase year-over-year.
- Starling Oncology, Inc. investment income, interest for the quarter ending 2020-12-31 was $59.25K.
- Starling Oncology, Inc. investment income, interest for fiscal 2020 was $254.15K.
| Period end | Investment Income, Interest | Investment Income, Interest 2 month | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|---|---|
| 2021-09-30 | $5.80K 10-Q/A · filed 2021-12-14 | $12.52K derived: sum of 2 quarters · filed 2021-12-14 | $58.47K 10-Q/A · filed 2021-12-14 | $117.72K derived: sum of 4 quarters · filed 2021-12-14 | ||
| 2021-06-30 | $6.72K 10-Q · filed 2021-08-16 | $52.68K 10-Q · filed 2021-08-16 | $111.92K derived: sum of 3 quarters · filed 2021-12-14 | $185.32K derived: sum of 4 quarters · filed 2021-12-14 | ||
| 2021-03-31 | $45.96K 10-Q · filed 2021-05-28 | $105.21K derived: sum of 2 quarters · filed 2021-12-14 | $178.60K derived: sum of 3 quarters · filed 2021-12-14 | $257.42K derived: sum of 4 quarters · filed 2021-12-14 | ||
| 2020-12-31 | $59.25K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2021-12-14 | $132.64K derived: sum of 2 quarters · filed 2021-12-14 | $211.46K derived: sum of 3 quarters · filed 2021-12-14 | $254.15K 10-K/A · filed 2021-12-14 | ||
| 2020-09-30 | $73.39K 10-Q/A · filed 2021-12-14 | $152.22K derived: sum of 2 quarters · filed 2021-12-14 | $194.90K 10-Q/A · filed 2021-12-14 | |||
| 2020-06-30 | $78.82K 10-Q · filed 2021-08-16 | $121.51K 10-Q · filed 2021-08-16 | ||||
| 2020-03-31 | $43.00K 10-Q · filed 2020-05-08 | $42.69K 10-Q · filed 2021-05-28 | ||||
| 2019-12-31 | $0.00 10-K/A · filed 2021-12-14 |